Amarin Corp Plc (AMRN)

[KCSVEN]

Seems like 10-12 billion is reasonable after FDA official label, EVAPORATE and Generics settle. Then it comes down to executing on sales and marketing, or BO. Since most of that is expected to happen we could get there anytime by year end. Even the worst case for peak sales mentioned makes it worth that, I mean the cash flow over the next 10 years they could buy the company outright on buybacks at those levels and market is forward thinking.